New renal denervation procedure treats overactive nerves that can elevate blood pressure
Brooklyn, New York – (August 26, 2024) – Maimonides Health announced that it has become the first hospital in Brooklyn to offer a groundbreaking renal denervation (RDN) procedure for patients with high blood pressure. This minimally invasive treatment, recently approved by the FDA, targets overactive nerves near the kidneys to help control hypertension in conjunction with lifestyle changes and medication.
The landmark procedure, performed under the expert care of Dr. Sergey Ayzenberg, Associate Director of Interventional Cardiology, Maimonides Health, provides patients with a new option to manage their blood pressure and reduce serious health risks.
The Symplicity Spyral™ renal denervation (RDN) system is the first catheter-based approach using radiofrequency energy that complements medications and lifestyle modifications to help reduce blood pressure. The minimally invasive procedure targets nerves near the kidneys that can become overactive and cause high blood pressure. The procedure is approved for use as a complementary treatment in patients with hypertension when lifestyle changes and antihypertensive medications do not adequately control blood pressure.
Hypertension is the single largest contributor to death and affects about 50% of U.S. adults. Of the U.S. adults who are aware of their hypertension, about 80% do not have it under control. In Brooklyn, there are more than 900,000 individuals living with hypertension, or 29% of the population.
This new blood pressure procedure is clinically proven to help reduce high blood pressure, which can lower serious health risks. After mild sedation, the doctor inserts a very thin tube into the artery leading to the kidney. The doctor then administers energy to calm the excessive activity of the nerves connected to the kidney. The tube is removed, leaving no implant behind.
“High blood pressure is a significant health problem, and for many of our patients with this condition, medication and lifestyle changes don’t provide enough control,” said Dr. Sergey Ayzenberg. “The renal denervation procedure can provide patients with a blood pressure reduction benefit that is ‘always on’ and doesn’t require a permanent implant. We are looking forward to the future of hypertension care and are proud to be at the forefront, offering innovative solutions and peace of mind to the people of Brooklyn.”
Maimonides Heart & Vascular Institute is a national leader in heart and vascular excellence, innovation, and outstanding patient outcomes, offering the most advanced techniques for diagnosing and treating all types of cardiovascular disorders. We are in the top 1% in the U.S. for heart attack survival and top 1% in New York for coronary intervention outcomes. Maimonides Heart & Vascular Institute is recognized by U.S. News & World Report for High Performance in Heart Failure and Heart Bypass Surgery, and is a Healthgrades Five-Star Rating Recipient for Defibrillator and Pacemaker Procedures.
###
Maimonides Health is Brooklyn’s largest healthcare system, serving over 320,000 patients each year through the system’s 3 hospitals, 1,800+ physicians and more than 80 community-based practices and outpatient centers. The system is anchored by Maimonides Medical Center, one of the nation’s largest independent teaching hospitals and home to centers of excellence in numerous specialties and Maimonides Midwood Community Hospital (formerly New York Community Hospital), a 130-bed adult medical-surgical hospital; and Maimonides Children’s Hospital, Brooklyn’s only children’s hospital and only pediatric trauma center.
Maimonides’ clinical programs rank among the best in the country for patient outcomes, including its Heart and Vascular Institute, Neurosciences Institute, Bone and Joint Center, and Cancer Center. Maimonides is an affiliate of Northwell Health and a major clinical training site for SUNY Downstate College of Medicine. For additional information, please visit www.maimo.org and follow us on LinkedIn, X, Instagram, and Facebook, YouTube, and TikTok.